A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study

AIM: To assess the efficacy and safety of latanoprostene bunod (LBN) compared with latanoprost 0.005%, and to determine the optimum drug concentration(s) of LBN in reducing intraocular pressure (IOP) in subjects with open angle glaucoma or ocular hypertension. METHODS: Randomised, investigator-maske...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Ophthalmol
Main Authors: Weinreb, Robert N, Ong, Tuyen, Scassellati Sforzolini, Baldo, Vittitow, Jason L, Singh, Kuldev, Kaufman, Paul L
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2015
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4453588/
https://ncbi.nlm.nih.gov/pubmed/25488946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2014-305908
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados